Physician profile
Julia Holtmann
NPI 1598046450
$426.57
in general payments reported to CMS, 2019-2025
10 companies · $427 in 2025
The $427 reported for 2025 was more than what a typical Neurology With Special Qualifications In Child Neurology provider received nationally (typical 2025 total: $275).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $427.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $427.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $426.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tolmar, INC. | $135.25 | 2025 | Fensolvi |
| Azurity Pharmaceuticals, INC. | $59.25 | 2025 | Triptodur |
| Grifols USA, LLC | $54.93 | 2025 | Xembify |
| Endo USA, INC. | $50.67 | 2025 | Supprelin |
| Ucb, INC. | $37.94 | 2025 | Fintepla |
| Takeda Pharmaceuticals U.S.A., INC. | $23.56 | 2025 | Eohilia |
| Alexion Pharmaceuticals, INC. | $21.62 | 2025 | Koselugo |
| Acadia Pharmaceuticals INC | $15.51 | 2025 | Daybue |
| Neos Therapeutics, LP | $15.07 | 2025 | Cotempla Xr-Odt |
| Corium, LLC | $12.77 | 2025 | Azstarys |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Holtmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.